David Nierengarten
Stock Analyst at Wedbush
Total Price Targets
15
Stocks Covered
12
Sectors
Healthcare
Most Recent
Apr 13, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by David Nierengarten
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| SYRE | Spyre Therapeutics, Inc. | $80.00 | $70.20 | +14.0% | 1 | Apr 13, 2026 |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | $50.00 | $54.56 | -8.4% | 1 | Jan 13, 2026 |
| COGT | Cogent Biosciences, Inc. | $38.00 | $36.84 | +3.2% | 1 | Nov 10, 2025 |
| ANAB | AnaptysBio, Inc. | $50.00 | $66.67 | -25.0% | 2 | Nov 10, 2025 |
| NTLA | Intellia Therapeutics, Inc. | $9.00 | $13.20 | -31.8% | 2 | Oct 30, 2025 |
| IRON | Disc Medicine, Inc. | $110.00 | $67.31 | +63.4% | 2 | Oct 17, 2025 |
| XNCR | Xencor, Inc. | $26.00 | $12.88 | +101.9% | 1 | Aug 7, 2025 |
| ORKA | Oruka Therapeutics, Inc. | $40.00 | $62.83 | -36.3% | 1 | Sep 4, 2024 |
| PRME | Prime Medicine, Inc. | $12.00 | $3.42 | +250.4% | 1 | Apr 2, 2024 |
| IMNM | Immunome, Inc. | $33.00 | $22.80 | +44.7% | 1 | Apr 1, 2024 |
| ORIC | ORIC Pharmaceuticals, Inc. | $20.00 | $9.88 | +102.4% | 1 | Mar 12, 2024 |
| MGNX | MacroGenics, Inc. | $32.00 | $3.16 | +912.7% | 1 | Jun 16, 2021 |
Recent Activity
- Apr 13, 2026— Set$80.00price target onSYRE(Spyre Therapeutics, Inc.)
- Jan 13, 2026— Set$50.00price target onKNSA(Kiniksa Pharmaceuticals, Ltd.)
- Nov 10, 2025— Set$50.00price target onANAB(AnaptysBio, Inc.)
- Nov 10, 2025— Set$38.00price target onCOGT(Cogent Biosciences, Inc.)
- Oct 30, 2025— Set$9.00price target onNTLA(Intellia Therapeutics, Inc.)
- Oct 17, 2025— Set$110.00price target onIRON(Disc Medicine, Inc.)
- Oct 15, 2025— Set$70.00price target onANAB(AnaptysBio, Inc.)
- Aug 7, 2025— Set$26.00price target onXNCR(Xencor, Inc.)
- Sep 4, 2024— Set$40.00price target onORKA(Oruka Therapeutics, Inc.)
- Apr 2, 2024— Set$12.00price target onPRME(Prime Medicine, Inc.)
- Apr 1, 2024— Set$43.00price target onIRON(Disc Medicine, Inc.)
- Apr 1, 2024— Set$33.00price target onIMNM(Immunome, Inc.)
- Mar 12, 2024— Set$20.00price target onORIC(ORIC Pharmaceuticals, Inc.)
- Feb 3, 2022— Set$108.00price target onNTLA(Intellia Therapeutics, Inc.)
- Jun 16, 2021— Set$32.00price target onMGNX(MacroGenics, Inc.)
Frequently Asked Questions
Who is David Nierengarten?
David Nierengarten is a stock analyst at Wedbush covering 12 stocks primarily in Healthcare. They have issued 15 price targets since Jun 16, 2021.
What stocks does David Nierengarten cover?
David Nierengarten currently covers 12 stocks, including ANAB, NTLA, IRON, SYRE, KNSA.
What is David Nierengarten's latest price target?
David Nierengarten's most recent price target was $80.00 on SYRE (Spyre Therapeutics, Inc.), set on Apr 13, 2026.
What is David Nierengarten's highest price target?
David Nierengarten's highest issued price target is $110.00 on IRON, set on Oct 17, 2025.
More Analysts at Wedbush
Coverage based on publicly published price targets. Not investment advice.